Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry

Kenneth J C Lim, Cameron Wellard, Elizabeth Moore, Betty Gration, Bradley Augustson, Peter Mollee, Jennifer Zhang, Nicole Wong Doo, Sabine Ringkowski, Adam Bryant, Slavisa Ninkovic, Nada Hamad, Georgia McCaughan, Shaji Kumar, Andrew Spencer, Hang Quach

Blood (2024) 144 (Supplement 1): 1951.

https://doi.org/10.1182/blood-2024-207609

Published: 2024

Journal Articles

Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 Dreamm-7 Trial

Blood (2024) 144 (Supplement 1): 772.

https://doi.org/10.1182/blood-2024-200336

Published: 2024

Journal Articles

Multiple Myeloma in the Culturally and Linguistically Diverse Southwestern Sydney, Australia

A-M Joëlle Marivel, Tara L Roberts, Joseph Descallar, Win Pa Pa Aung, Jonathan Cheng, Therese M Becker, Alexander James, Yafeng Ma, Adam Bryant, Silvia Ling

Blood (2023) 142 (Supplement 1): 6642.

https://doi.org/10.1182/blood-2023-185193

Published: 2023

Journal Articles

A Phase I Study of RO7297089, a B-Cell Maturation Antigen (BCMA)-CD16a Bispecific Antibody in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Torben Plesner, Simon J Harrison, Hang Quach, Cindy H. Lee, Adam Bryant, Annette Juul Vangsted, Jane Estell, Michel Delforge, Fritz Offner, Patrick Twomey, Voleak Choeurng, Junyi Li, Robert Hendricks, Teiko Sumiyoshi, Karen Miller, Eunpi Choi, Fredrik H. Schjesvold

Blood (2021) 138 (Supplement 1): 2755.

https://doi.org/10.1182/blood-2021-147418

Published: 2021

Journal Articles

Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres

Georgia J McCaughan, MBBS, Anvita Verma, MBBS, Silvia Ling, MBBS, PhD, Orly Lavee, MBBS FRACP FRCPA, John Moore, MB.BS, MD FRACP, FRCPA, Adam Bryant, MBBS (Hon) PhDFRACP FRCPA

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-139269

Published: 2020

Journal Articles

Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study

Georgia J McCaughan, MBBS, Steven Tran, BEng MBiomedE, Simon Durrant, MBBS FRCP FRCPath, Simon J Harrison, MBBS MRCP (UK) PhDFRCPath (UK) FRACP, James Morton, MBBS BSci (MD FRACP FRCPA GAICD, Noemi Horvath, MB ChB FRACP FRCPA, Andrew Spencer, Ian H. Kerridge, FRACP FRCPA MPhil BA, Jeremy An Ke Er, MBBS, Luani Barge, MChD, BSc, Adam Bryant, MBBS (Hon) PhDFRACP FRCPA, Robin J Filshie, MBChB, PhD FRACP, FRCPA, Emily Choong, BSc MBBS, Hock Choong Lai, MBBS, FRACP, FRCPA, Campbell Tiley, MBBS FRACP, Anthony K Mills, MBBS FRACP FRCPA, Andrew Butler, MB ChB(Edin), MRCP, MRCPath, John Moore, MB.BS, MD FRACP, FRCPA, Mark Hertzberg, MBBS PhDFRACP FRCPA, Glen A Kennedy, MBBS FRACP FRCPA, P. Joy Ho, MB.BS. (Hons), D.Phil (Oxon), FRACP, FRCPA, FFSc(RCPA), M Hasib Sidiqi, MBBS, John Bashford, BSc MBBS FRACP FRCPA, David Routledge, BSc (Hons) MBChB MSc PGCert MRCP FRCPath UK RACP, Kerry Taylor, MBBS(Hons) FRACP FRCPA, Cindy H. Lee, MBBS FRACP FRCPA, Anna Kalff, MBBS (Hons) FRACP FRCPA, Wei Xia, MBBS PhD, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-138991

Published: 2020

Journal Articles

Pre-Salvage ISS and Other Important Outcome Predictors in CD34 Selected Allogeneic Hematopoietic Cell Transplant for Multiple Myeloma

Adam Bryant, MD MSc, Patrick Hilden, MS, Sergio Giralt, MD, Miguel-Angel Perales, MD, Guenther Koehne, MD PhD

Blood (2018) 132 (Supplement 1): 3473.

https://doi.org/10.1182/blood-2018-99-118625

Published: 2018

Journal Articles

Efficacy of Donor Lymphocyte Infusion in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience

Adam Bryant, MD, Sean M. Devlin, PhD, H.R. Castro-Malaspina, MD, Ann A. Jakubowski, MD PhD, Molly Maloy, MS, Esperanza B. Papadopoulos, MD, Sergio A. Giralt, MD, Miguel-Angel Perales, MD

Blood (2017) 130 (Supplement 1): 3277.

https://doi.org/10.1182/blood.V130.Suppl_1.3277.3277

Published: 2017

Journal Articles

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Adam Bryant, MD, Ranjeeta Mallick, Lothar B. Huebsch, MD, David S. Allan, MD FRCPC, Harold Atkins, MDFRCPC, Grizel Anstee, MD, Isabelle Bence-Bruckler, MD FRCPC, Linda Hamelin, Michael Hodgins, MD, Mitchell Sabloff, MDM, Nicholas Scrivens, Dawn C. Maze, MDFRCPC,MSc, Christopher N. Bredeson, MD MSc, FRCPC, Natasha Kekre, MDMPH, FRCPC

Blood (2016) 128 (22): 5782.

https://doi.org/10.1182/blood.V128.22.5782.5782

Published: 2016

Journal Articles

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

Kristin A Rand, PhD, M.P.H., Chi Song, M.S., Amie E. Hwang, PhD, M.P.H., Carol A. Huff, MD, Leon Bernal-Mizrachi, MD, Michael H Tomasson, MD, Sikander Ailawadhi, MD, David J. Van Den Berg, PhD, Xin Sheng, PhD, John J. Graff, PhD, M.S., David V. Conti, PhD, Todd Zimmerman, MD, Edward Peters, D.MD S.M, Sc.D., Seema Singhal, MD, Cathryn H. Bock, PhD, Karen Pawlish, M.P.H., Graham A Colditz, MD, Dr.PH., Xin Sheng, PhD, Alexander Stram, M.S., Sara S. Strom, PhD, Benjamin Rybicki, PhD, Rick Kittles, PhD, Howard Terebelo, DO, Janet Stanford, PhD, MPH, Phyllis J. Goodman, PhD, Sonja I Berndt, PhD, John Carpten, PhD, Anselm JM Hennis, MSc,PhD MRCP, FRCP, Lisa Chu, PhD, M.P.H., Graham Casey, PhD, W R Driver, MSPH, Eric A. Klein, MD, M. Christina Leske, MD MPH, Esther John, PhD, Adam Bryant Murphy, MD, Christine Neslund-Dudas, PhD, Victoria L. Stevens, PhD, Curtis Pettaway, MD, Wei Zheng, MD PhD MPH, Suh-Yuh Wu, M.A., John Witte, PhD, Siqun Lilly Zheng, MD, Jianfeng Xu, MD,Dr.PH, Nikhil C. Munshi, MD, Ann Hsing, PhD, Sue Ingles, PhD, Jayesh Mehta, MD, Lisa B. Signorello, PhD, Stephen Jacob Chanock, MD, Barbara Nemesure, PhD, Ann M Mohrbacher, MD, Nalini Janakiraman, MD, William J Blot, MD, Brian E. Henderson, MD, Laurence N. Kolonel, MD PhD, Kenneth C. Anderson, MD, Brian C-H Chiu, PhD, Jeffrey Zonder, MD, Robert Z. Orlowski, PhD MD, Sagar Lonial, MD, Daniel O. Stram, PhD, Christopher Haiman, Sc.D., Wendy Cozen, DO, MPH

Blood (2014) 124 (21): 2030.

https://doi.org/10.1182/blood.V124.21.2030.2030

Published: 2014

Journal Articles

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Adam Bryant, MD, Elizabeth Pringle, MD, Christopher Bredeson, MD MSc, FRCPC, David S. Allan, MD MSc, Grizel Anstee, Isabelle Bence-Bruckler, Linda Hamelin, Harry Spencer Hopkins, Lothar B. Huebsch, MD, Mitchell Sabloff, MDM, Dawn C. Sheppard, MDFRCPC,MSc, Jason Tay, MD MSc, Harold Atkins, MD

Blood (2014) 124 (21): 3996.

https://doi.org/10.1182/blood.V124.21.3996.3996

Published: 2014

Journal Articles

Utility of Pre-Induction Cardiac Function Testing in Patients with Newly Diagnosed AML

Adam Bryant, MD, Dawn Sheppard, MD, MSc, FRCPC, Christopher Bredeson, MD, MSc, FRCPC, Mitchell Sabloff, MDCM, FRCPC, MSc

Blood (2012) 120 (21): 2068.

https://doi.org/10.1182/blood.V120.21.2068.2068

Published: 2012

NARROW

Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry

Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 Dreamm-7 Trial

Multiple Myeloma in the Culturally and Linguistically Diverse Southwestern Sydney, Australia

A Phase I Study of RO7297089, a B-Cell Maturation Antigen (BCMA)-CD16a Bispecific Antibody in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres

Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study

Pre-Salvage ISS and Other Important Outcome Predictors in CD34 Selected Allogeneic Hematopoietic Cell Transplant for Multiple Myeloma

Efficacy of Donor Lymphocyte Infusion in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Utility of Pre-Induction Cardiac Function Testing in Patients with Newly Diagnosed AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only